A Stanford Medicine clinical trial has found that low-dose buprenorphine, a cornerstone of medication-assisted treatment for opioid use disorder, may also dramatically extend the anti-suicidal effects of ketamine infusions in patients with major depressive disorder. …
A newly approved, high-dose naloxone nasal spray has secured a spot on the formulary of a major national health plan, a development with direct relevance for anyone going through opioid detox or supporting a loved …
A landmark final rule from the Drug Enforcement Administration (DEA), published June 9, 2026, formally eliminates the long-standing X-waiver requirement for medication-assisted treatment of opioid use disorder. It also extends the window for administering injectable …
For residents of Seattle’s tiny home villages, getting to a medical detox clinic has meant navigating buses, waiting lists and a system not built for people without stable housing. Starting June 15, a clinic-on-wheels will …
A man is dead because of frog poison, and medical experts are raising urgent alarms. It’s the latest casualty of a growing “detox” trend that has nothing to do with medical detox and everything to …